A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSL
Clinical trial NCT05036577 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05036577
- Sponsor
- Huashan Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-10
- Primary completion
- 2023-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.